[go: up one dir, main page]

WO2019059872A3 - Ivermectin topical formulation - Google Patents

Ivermectin topical formulation Download PDF

Info

Publication number
WO2019059872A3
WO2019059872A3 PCT/TR2018/050519 TR2018050519W WO2019059872A3 WO 2019059872 A3 WO2019059872 A3 WO 2019059872A3 TR 2018050519 W TR2018050519 W TR 2018050519W WO 2019059872 A3 WO2019059872 A3 WO 2019059872A3
Authority
WO
WIPO (PCT)
Prior art keywords
topical formulation
ivermectin
ivermectin topical
rosacea
formulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2018/050519
Other languages
French (fr)
Other versions
WO2019059872A2 (en
Inventor
Mehmet Koray GÜRBÜZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Tic AS
Original Assignee
Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Tic AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Tic AS filed Critical Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Tic AS
Publication of WO2019059872A2 publication Critical patent/WO2019059872A2/en
Publication of WO2019059872A3 publication Critical patent/WO2019059872A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to ivermectin topical formulation for use in the treatment of rosacea. Ivermectin is formulated to be active in the oil phase to improve hydrolytic stability.
PCT/TR2018/050519 2017-09-22 2018-09-22 Ivermectin topical formulation Ceased WO2019059872A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/14097 2017-09-22
TR2017/14097A TR201714097A2 (en) 2017-09-22 2017-09-22 IVERMEKTIN TOPIC FORMULATION

Publications (2)

Publication Number Publication Date
WO2019059872A2 WO2019059872A2 (en) 2019-03-28
WO2019059872A3 true WO2019059872A3 (en) 2019-06-20

Family

ID=65811450

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050519 Ceased WO2019059872A2 (en) 2017-09-22 2018-09-22 Ivermectin topical formulation

Country Status (2)

Country Link
TR (1) TR201714097A2 (en)
WO (1) WO2019059872A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150306027A1 (en) * 2003-04-24 2015-10-29 Galderma S.A. Topical application of ivermectin for the treatment of dermatological conditions/afflictions
US20160303152A1 (en) * 2015-04-15 2016-10-20 Gavis Pharmaceuticals Topical Composition of Ivermectin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150306027A1 (en) * 2003-04-24 2015-10-29 Galderma S.A. Topical application of ivermectin for the treatment of dermatological conditions/afflictions
US20160303152A1 (en) * 2015-04-15 2016-10-20 Gavis Pharmaceuticals Topical Composition of Ivermectin

Also Published As

Publication number Publication date
TR201714097A2 (en) 2018-10-22
WO2019059872A2 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
WO2018136264A9 (en) Pyridine compounds as allosteric shp2 inhibitors
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2019005009A (en) 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh.
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
WO2015070224A3 (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
WO2014152029A3 (en) Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EP4620528A3 (en) Bipyrazole derivatives as jak inhibitors
HK1203361A1 (en) Topical oil composition for the treatment of fungal infections
MX2018010788A (en) Ophthalmological composition.
EA201600434A1 (en) APPLICATION OF DERIVATIVES OF BENZIMIDAZOLPROLINE
WO2015017393A3 (en) Piperazine derivatives as hiv protease inhibitors
MX376183B (en) COMPOSITIONS FOR THE TREATMENT OF ROSACEA.
DOP2016000076A (en) TIENOURACILCARBOXAMIDAS AND USES OF THE SAME
MX2019010218A (en) Pyrazole derivatives as bromodomain inhibitors.
WO2014152437A3 (en) Methods of use for an antimicrobial peptide
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same
HK1212978A1 (en) Novel derivatives of sinapinic acid
MX373177B (en) TREATMENT METHODS FOR DYSKINESIA AND RELATED DISORDERS.
WO2015082590A3 (en) Bis-mmf derivatives
WO2015079469A8 (en) Daphne laureola extracts in the treatment of dermopathies
PH12016500726A1 (en) Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation
WO2019059872A3 (en) Ivermectin topical formulation
IL272999A (en) Topical compositions for the treatment of cutaneous leishmaniasis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18857835

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18857835

Country of ref document: EP

Kind code of ref document: A2